Feasibility/eligibility of T-wave alternans testing in patients with heart failure: should we rethink our current modus operandi?: reply.
British Heart Foundation Cardiovascular Research CentreUniversity of Glasgow126 University PlaceGlasgow G12 8TAUK.European Journal of Heart Failure (Impact Factor: 5.25). 04/2012; DOI: 10.1093/eurjhf/hfs050
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.